A placebo-controlled, multiple dose, double-blind, randomized study to assess the efficacy and safety of Kappaproct as an add-on to current practice in chronic active treatment refractory ulcerative colitis patients elected for colectomy. (INDEX)
1st January 2012
Team: Professor Christopher Hawkey.
|Professor Christopher Hawkey||Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify…|